PRELAJ, ARSELA
 Distribuzione geografica
Continente #
NA - Nord America 831
EU - Europa 393
AS - Asia 162
AF - Africa 11
SA - Sud America 10
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.408
Nazione #
US - Stati Uniti d'America 829
IT - Italia 264
SG - Singapore 55
VN - Vietnam 44
IE - Irlanda 24
CN - Cina 23
AT - Austria 21
GB - Regno Unito 19
FI - Finlandia 12
DE - Germania 10
IN - India 8
BR - Brasile 7
HK - Hong Kong 7
SE - Svezia 7
CI - Costa d'Avorio 6
FR - Francia 6
NL - Olanda 6
BJ - Benin 5
ID - Indonesia 4
BE - Belgio 3
DK - Danimarca 3
ES - Italia 3
JP - Giappone 3
KG - Kirghizistan 3
TH - Thailandia 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
CH - Svizzera 2
CL - Cile 2
EE - Estonia 2
PL - Polonia 2
PT - Portogallo 2
RS - Serbia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
BG - Bulgaria 1
CA - Canada 1
CZ - Repubblica Ceca 1
GE - Georgia 1
IL - Israele 1
IM - Isola di Man 1
JM - Giamaica 1
LV - Lettonia 1
PH - Filippine 1
PK - Pakistan 1
RU - Federazione Russa 1
TR - Turchia 1
Totale 1.408
Città #
Chandler 187
Fairfield 105
Ashburn 56
Houston 41
Milan 41
Seattle 41
Cambridge 40
Wilmington 33
Woodbridge 31
Singapore 26
Dublin 24
Lawrence 23
Boardman 21
San Diego 20
Vienna 19
Redmond 17
Ann Arbor 16
Dong Ket 16
Princeton 13
Rome 12
Medford 11
Redwood City 10
Helsinki 7
Hong Kong 7
Abidjan 6
Cotonou 5
Lappeenranta 5
Beijing 4
Bergamo 4
Caravaggio 4
Naples 4
Padova 4
Uxbridge 4
Americana 3
Ancona 3
Bari 3
Bishkek 3
Copenhagen 3
Cortenuova 3
Hounslow 3
London 3
Münster 3
New York 3
Norwalk 3
Palermo 3
Perugia 3
Philadelphia 3
Portland 3
São Paulo 3
Zhengzhou 3
Abbiategrasso 2
Ada 2
Baku 2
Brusciano 2
Brussels 2
Caen 2
Dubai 2
Frankfurt am Main 2
Genoa 2
Gurgaon 2
Hangzhou 2
Jakarta 2
Jinan 2
Kaohsiung City 2
Los Angeles 2
Madrid 2
Maida 2
Miami 2
Mirandela 2
Montecchio Emilia 2
Mountain View 2
Newark 2
Pavia 2
Rizziconi 2
Salerno 2
Santiago Metropolitan 2
Shenyang 2
Solna 2
Surabaya 2
Tallinn 2
Torino 2
Venice 2
Acqui Terme 1
Acton 1
Amsterdam 1
Augusta 1
Azzano Decimo 1
Berlin 1
Boulder 1
Buenos Aires 1
Chiswick 1
Cincinnati 1
Dallas 1
Douglas 1
Gambara 1
Gambolò 1
Groningen 1
Ho Chi Minh City 1
Islington 1
Istanbul 1
Totale 990
Nome #
Abstract PO-065: Artificial intelligence to improve selection for NSCLC patients treated with immunotherapy 85
ALK/ROS1 rearrangements: A real hallmark for thromboembolic events in cancer patients? 78
DiM: Prognostic Score for Second- or Further-line Immunotherapy in Advanced Non–Small-Cell Lung Cancer: An External Validation 74
EPSILoN: A Prognostic Score Using Clinical and Blood Biomarkers in Advanced Non–Small-cell Lung Cancer Treated With Immunotherapy 71
Integrating clinical and biological prognostic biomarkers in patients with advanced NSCLC treated with immunotherapy: the DEMo score system 68
Efficacy and safety of immunotherapy in elderly patients with non-small cell lung cancer 64
Epsilon: A prognostic score for immunotherapy in advanced non-small-cell lung cancer: A validation cohort 64
Choosing wisely first line immunotherapy in non-small cell lung cancer (NSCLC): what to add and what to leave out 61
Real-world data to build explainable trustworthy artificial intelligence models for prediction of immunotherapy efficacy in NSCLC patients 58
Is there an interplay between immune checkpoint inhibitors, thromboprophylactic treatments and thromboembolic events? Mechanisms and impact in non-small cell lung cancer patients 51
Cell-free DNA from cerebrospinal fluid can be used to detect the EGFR mutation status of lung adenocarcinoma patients with central nervous system metastasis 51
Gastrointestinal stromal tumors and second primary malignancies: a retrospective monocentric analysis 49
Characterization of patients with metastatic non-small-cell lung cancer obtaining long-term benefit from immunotherapy 49
Immunotherapy beyond progression in patients with advanced non-small cell lung cancer 48
Relationship Between Programmed Death Receptor-Ligand 1 Expression and Response to Checkpoint Inhibitor Immunotherapy in Pulmonary Sarcomatoid Carcinoma: A Pooled Analysis 40
Beyond first-line immunotherapy: Potential therapeutic strategies based on different pattern progressions: Oligo and systemic progression 40
Treatment patterns among patients with malignant pleural mesothelioma: An Italian, population-based nationwide study 38
Immunotherapy in advanced Non-Small Cell Lung Cancer patients with poor performance status: The role of clinical-pathological variables and inflammatory biomarkers 35
Novel emerging molecular targets in non-small cell lung cancer 30
The Prognostic Role of TNM Staging Compared With Tumor Volume and Number of Pleural Sites in Malignant Pleural Mesothelioma 28
Artificial intelligence for predictive biomarker discovery in immuno-oncology: a systematic review 27
The EU-funded I3LUNG Project: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy 27
Isochorismatase domain-containing protein 1 (ISOC1) participates in DNA damage repair and inflammation-related pathways to promote lung cancer development 26
Carcinomatosis under control by osimertinib in EGFR and TP53 mutated lung adenocarcinoma 25
Poziotinib for EGFR and HER2 exon 20 insertion mutation in advanced NSCLC: Results from the expanded access program 24
SMO mutations confer poor prognosis in malignant pleural mesothelioma 22
APOLLO 11 Project, Consortium in Advanced Lung Cancer Patients Treated With Innovative Therapies: Integration of Real-World Data and Translational Research 20
Case Report: Exceptional Response to Poziotinib in Patient with Metastatic Non-Small Cell Lung Cancer With EGFR Exon 20 Insertion Mutation 20
Evaluation of Drug-Drug Interactions in EGFR-Mutated Non-Small-Cell Lung Cancer Patients during Treatment with Tyrosine-Kinase Inhibitors 20
Exploring the role of respiratory microbiome in lung cancer: A systematic review 19
Uncommon targets in non-small cell lung cancer: Everyone wants a slice of cake 19
Immune-Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer With Uncommon Histology 18
Machine Learning Using Real-World and Translational Data to Improve Treatment Selection for NSCLC Patients Treated with Immunotherapy 18
Prognostic scores including peripheral blood-derived inflammatory indices in patients with advanced non-small-cell lung cancer treated with immune checkpoint inhibitors 15
178P Explainable radiomics, machine and deep learning models to predict immune-checkpoint inhibitor treatment efficacy in advanced non-small cell lung cancer patients 15
Circulating Fatty Acid Profile as a Biomarker for Immunotherapy in Advanced Non-Small Cell Lung Cancer 14
Systemic lupus erythematosus reactivation after chemoimmunotherapy in preexisting autoimmune disease 13
Prognostic role of neutrophil-to-lymphocyte ratio and EPSILoN score in advanced non-small-cell lung cancer patients treated with first-line chemo-immunotherapy 7
MetaLung: Towards a Secure Architecture for Lung Cancer Patient Care on the Metaverse 7
Novel patterns of progression upon immunotherapy in other thoracic malignancies and uncommon populations 6
Successful treatment of triple EGFR mutation T785A/L861Q/H297_E298 with afatinib 2
The impact of decision tools during oncological consultation with lung cancer patients: A systematic review within the I3LUNG project 2
Totale 1.448
Categoria #
all - tutte 8.744
article - articoli 8.567
book - libri 0
conference - conferenze 177
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.488


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021449 0 40 61 1 27 3 30 11 15 74 137 50
2021/2022267 34 27 26 11 11 27 7 17 11 12 40 44
2022/2023362 40 49 10 45 48 32 4 27 58 21 20 8
2023/2024280 13 29 12 14 11 20 7 28 29 21 19 77
2024/202590 32 19 29 10 0 0 0 0 0 0 0 0
Totale 1.448